Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 5/20 | 0.64 |
| ▸ | MEN1 | O00255 | 4/20 | 0.64 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.64 |
| ▸ | MAPK1 | P28482 | 3/20 | 0.64 |
| ▸ | PTPRC | P08575 | 6/20 | 0.50 |
| ▸ | CDC25B | P30305 | 3/20 | 0.48 |
| ▸ | CDC25A | P30304 | 1/20 | 0.48 |
| ▸ | POLB | P06746 | 3/20 | 0.46 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.46 |
| ▸ | LMNA | P02545 | 2/20 | 0.46 |
| ▸ | BCHE | P06276 | 2/20 | 0.46 |
| ▸ | THRB | P10828 | 2/20 | 0.46 |
| ▸ | CES1 | P23141 | 2/20 | 0.46 |
| ▸ | RECQL | P46063 | 2/20 | 0.46 |
| ▸ | PTPN1 | P18031 | 2/20 | 0.46 |
| ▸ | IDO1 | P14902 | 2/20 | 0.46 |
| ▸ | HPGD | P15428 | 2/20 | 0.46 |
| ▸ | PTPN22 | Q9Y2R2 | 2/20 | 0.46 |
| ▸ | PKM | P14618 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29650595 | 0.93 | MEN1 (0.57) | MAPTMEN1KMT2AMAPK1PTPRC | |
| SCHEMBL4337875 | 0.93 | MEN1 (0.57) | MAPTMEN1KMT2AMAPK1PTPRC | |
| SCHEMBL826206 | 0.79 | — | — | |
| SCHEMBL16225115 | 0.79 | MEN1 (1.00) | MAPTMEN1KMT2AMAPK1PTPRC | |
| SCHEMBL30184802 | 0.79 | MEN1 (1.00) | MAPTMEN1KMT2AMAPK1PTPRC | |
| 2-Bromo-1,4-Naphthoquinone SCHEMBL312893 | 0.76 | PTPRC (0.68) | MAPTMEN1KMT2AMAPK1PTPRC | |
| 2-Bromo-1,4-Naphthoquinone SCHEMBL29633250 | 0.76 | PTPRC (0.68) | MAPTMEN1KMT2AMAPK1PTPRC | |
| SCHEMBL3444897 | 0.75 | CDC25B (0.57) | MAPTMEN1KMT2AMAPK1PTPRC | |
| SCHEMBL2971465 | 0.75 | MAPK1 (0.42) | MAPTMEN1KMT2AMAPK1PTPRC | |
| SCHEMBL28493517 | 0.74 | MEN1 (0.43) | MAPTMEN1KMT2AMAPK1PTPRC |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 26 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116065410-B | Water-less dyeing process for polyester-cotton blended fabric | 浙江红利集团有限公司 | 2025-02-18 | — | — | CN | claimed |
| CN-114671829-B | Heterodiad taking indenone and dibenzoazepine as parent nucleus and hydrochloride thereof, preparation method and application thereof | 合肥工业大学 | 2023-07-25 | — | — | CN | claimed |
| CN-116065410-A | Water-less dyeing process for polyester-cotton blended fabric | 浙江红利集团有限公司 | 2023-05-05 | — | — | CN | claimed |
| WO-2008037604-A1 | NOVEL POLYBENZOFULVENE DERIVATIVES, SYNTHESIS AND USES THEREOF | UNIVERSITÀ DEGLI STUDI DI SIENA (IT) | 2008-04-03 | — | — | WO | claimed |
| CN-119678263-A | Slurry composition for negative electrode of secondary battery | 三菱铅笔株式会社 | 2025-03-21 | — | — | CN | disclosed |
| CN-116065410-B | Water-less dyeing process for polyester-cotton blended fabric | 浙江红利集团有限公司 | 2025-02-18 | — | — | CN | disclosed |
| US-11912693-B2 | Compounds for modulating S1P1 activity and methods of using the same | TREVENA, INC. (US) | 2024-02-27 | — | — | US | disclosed |
| CN-115895627-B | Sulfur-resistant corrosion inhibitor and preparation method thereof | 河南中原石油助剂有限公司 | 2023-10-31 | — | — | CN | disclosed |
| US-20230234946-A1 | COMPOUNDS FOR MODULATING S1P1 ACTIVITY AND METHODS OF USING THE SAME | TREVENA, INC. | 2023-07-27 | — | — | US | disclosed |
| CN-114671829-B | Heterodiad taking indenone and dibenzoazepine as parent nucleus and hydrochloride thereof, preparation method and application thereof | 合肥工业大学 | 2023-07-25 | — | — | CN | disclosed |
| CN-116282078-A | Salt recovery solution and method of using the same | 阿克福特斯技术有限公司 | 2023-06-23 | — | — | CN | disclosed |
| CN-116065410-A | Water-less dyeing process for polyester-cotton blended fabric | 浙江红利集团有限公司 | 2023-05-05 | — | — | CN | disclosed |
| EP-0871612-B1 | FUSED ISOINDOLONES AS INHIBITORS OF PROTEIN KINASE C | CEPHALON INC (US) | 2003-03-12 | — | — | EP | disclosed |
| EP-0885229-B1 | FUSED PYRROLO(2,3-C)CARBAZOLE-6-ONES WHICH POTENTIATE ACTIVITY OF GAMMA INTERFERON | CEPHALON INC (US) | 2000-08-02 | — | — | EP | disclosed |
| EP-0885229-A1 | FUSED PYRROLO(2,3-C)CARBAZOLE-6-ONES WHICH POTENTIATE ACTIVITY OF GAMMA INTERFERON | CEPHALON, INC. (US) | 1998-12-23 | — | — | EP | disclosed |
| US-5808060-A | Fused isoindolones | CEPHALON, INC. (US) | 1998-09-15 | — | — | US | disclosed |
| US-5801190-A | Fused pyrrolo 2,3-C! carbazole-6-ones | CEPHALON, INC. (US) | 1998-09-01 | — | — | US | disclosed |
| WO-1997031002-A1 | FUSED PYRROLO(2,3-C)CARBAZOLE-6-ONES WHICH POTENTIATE ACTIVITY OF GAMMA INTERFERON | CEPHALON, INC. (US) | 1997-08-28 | — | — | WO | disclosed |
| US-5616724-A | FOR POTENTIATION OF HUMAN INTERFERON-GAMMA; IMMUNOLOGY | CEPHALON, INC. (US) | 1997-04-01 | — | — | US | disclosed |
| CN-1087635-A | Novel thiazole derivative, its preparation method and medical composition thereof | YAMANOUCHI PHARMA CO LTD (JP) | 1994-06-08 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230234946-A1 | COMPOUNDS FOR MODULATING S1P1 ACTIVITY AND METHODS OF USING THE SAME | S1PR1, S1PR2, S1PR3 | MAPT 3799/4885MEN1 645/4885KMT2A 2682/4885 |
| US-11912693-B2 | Compounds for modulating S1P1 activity and methods of using the same | S1PR1, S1PR2, S1PR3 | MAPT 3799/4885MEN1 645/4885KMT2A 2682/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.